{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:06:53Z","timestamp":1790284013054,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T00:00:00Z","timestamp":1505260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bone.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T13:17:36Z","timestamp":1505222256000},"page":"251-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2"],"prefix":"10.1016","volume":"109","author":[{"given":"Eleanor","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-0436","authenticated-orcid":false,"given":"Alex N.","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bone.2017.09.004_bb0005","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGF beta-SMAD signal transduction: molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bone.2017.09.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2017.04.005","article-title":"Transforming growth factor-beta receptors and Smads: regulatory complexity and functional versatility","author":"Budi","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bone.2017.09.004_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cytogfr.2015.11.005","article-title":"Structural insights into BMP receptors: specificity, activation and inhibition","volume":"27","author":"Yadin","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.bone.2017.09.004_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrendo.2016.12","article-title":"BMP signalling in skeletal development, disease and repair","volume":"12","author":"Salazar","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2017.09.004_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"TGF-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.bone.2017.09.004_bb0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrg1178","article-title":"From developmental disorder to heritable cancer: it's all in the BMP\/TGF-[beta] family","volume":"4","author":"Waite","year":"2003","journal-title":"Nat. Rev. Genet."},{"issue":"5\u20136","key":"10.1016\/j.bone.2017.09.004_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cytogfr.2009.10.021","article-title":"Applications of small molecule BMP inhibitors in physiology and disease","volume":"20","author":"Hong","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.bone.2017.09.004_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bone.2017.09.004_bb0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/323703","article-title":"Germline mutations in BMPR1A\/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes","volume":"69","author":"Zhou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bone.2017.09.004_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/88919","article-title":"Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis","volume":"28","author":"Howe","year":"2001","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bone.2017.09.004_bb0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"issue":"303","key":"10.1016\/j.bone.2017.09.004_bb0060","doi-asserted-by":"crossref","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.bone.2017.09.004_bb0065","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1158\/0008-5472.CAN-14-1298","article-title":"ACVR1 mutations in DIPG: lessons learned from FOP","volume":"74","author":"Taylor","year":"2014","journal-title":"Cancer Res."},{"issue":"50","key":"10.1016\/j.bone.2017.09.004_bb0070","doi-asserted-by":"crossref","first-page":"E6882","DOI":"10.1073\/pnas.1507899112","article-title":"Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2","volume":"112","author":"Choi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bone.2017.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/bjc.1998.658","article-title":"Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies","volume":"78","author":"Autzen","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bone.2017.09.004_bb0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/path.2292","article-title":"BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype","volume":"214","author":"Darby","year":"2008","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.bone.2017.09.004_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2017.09.004_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.canlet.2015.07.032","article-title":"Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth","volume":"368","author":"Hover","year":"2015","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bone.2017.09.004_bb0095","first-page":"2095","article-title":"Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells","volume":"34","author":"Fotinos","year":"2014","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.bone.2017.09.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067533","article-title":"Bone morphogenetic proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion","volume":"8","author":"Owens","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.bone.2017.09.004_bb0105","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/onc.2014.189","article-title":"Inhibition of BMP signaling suppresses metastasis in mammary cancer","volume":"34","author":"Owens","year":"2015","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.bone.2017.09.004_bb0110","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-10-4374","article-title":"BMP4 promotes prostate tumor growth in bone through osteogenesis","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bone.2017.09.004_bb0115","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1002\/ijc.29220","article-title":"Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells","volume":"136","author":"Ali","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.bone.2017.09.004_bb0120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/jir.2012.0046","article-title":"Vasohibin-1 expression is regulated by transforming growth factor-\u03b2\/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells","volume":"33","author":"Shen","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"issue":"24","key":"10.1016\/j.bone.2017.09.004_bb0125","doi-asserted-by":"crossref","first-page":"12675","DOI":"10.18632\/oncotarget.2564","article-title":"A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy","volume":"5","author":"Raymond","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bone.2017.09.004_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"18","key":"10.1016\/j.bone.2017.09.004_bb0135","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1182\/blood-2010-10-313064","article-title":"Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation","volume":"117","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bone.2017.09.004_bb0140","doi-asserted-by":"crossref","first-page":"7290686","DOI":"10.1155\/2016\/7290686","article-title":"A survey of strategies to modulate the bone morphogenetic protein signaling pathway: current and future perspectives","volume":"2016","author":"Lowery","year":"2016","journal-title":"Stem Cells Int."},{"issue":"44","key":"10.1016\/j.bone.2017.09.004_bb0145","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva","volume":"287","author":"Chaikuad","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.bone.2017.09.004_bb0150","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","article-title":"Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors","volume":"18","author":"Cuny","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bone.2017.09.004_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/cb9002865","article-title":"In vivo structure activity relationship study of dorsomorphin analogs identifies selective VEGF and BMP inhibitors","volume":"5","author":"Hao","year":"2010","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.bone.2017.09.004_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.114.216903","article-title":"Specific activin receptor\u2013like kinase 3 inhibitors enhance liver regeneration","volume":"351","author":"Tsugawa","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bone.2017.09.004_bb0165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/cb300655w","article-title":"Development of an ALK2-biased BMP type I receptor kinase inhibitor","volume":"8","author":"Mohedas","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.bone.2017.09.004_bb0170","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bone.2017.09.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.111.242594","article-title":"Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis","volume":"32","author":"Derwall","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bone.2017.09.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062721","article-title":"A new class of small molecule inhibitor of BMP signaling","volume":"8","author":"Sanvitale","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.bone.2017.09.004_bb0185","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1021\/jm501177w","article-title":"Structure\u2013activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants","volume":"57","author":"Mohedas","year":"2014","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bone.2017.09.004_bb0190","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/13543776.2016.1217330","article-title":"Inhibitors of the bone morphogenetic protein (BMP) signaling pathway: a patent review (2008\u20132015)","volume":"26","author":"Hopkins","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"366","key":"10.1016\/j.bone.2017.09.004_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"Pt 1","key":"10.1016\/j.bone.2017.09.004_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1107\/S0907444905039107","article-title":"The integration of macromolecular diffraction data","volume":"62","author":"Leslie","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bone.2017.09.004_bb0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 4","key":"10.1016\/j.bone.2017.09.004_bb0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 3","key":"10.1016\/j.bone.2017.09.004_bb0215","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bone.2017.09.004_bb0220","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bone.2017.09.004_bb0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1107\/S0907444906005270","article-title":"Optimal description of a protein structure in terms of multiple groups undergoing TLS motion","volume":"62","author":"Painter","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bone.2017.09.004_bb0230","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.bone.2017.09.004_bb0235","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1074\/jbc.M114.604397","article-title":"Small molecules dorsomorphin and LDN-193189 inhibit myostatin\/GDF8 signaling and promote functional myoblast differentiation","volume":"290","author":"Horbelt","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2017.09.004_bb0240","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1107\/S0907444911010201","article-title":"Structural basis for compound C inhibition of the human AMP-activated protein kinase [alpha]2 subunit kinase domain","volume":"67","author":"Handa","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"2","key":"10.1016\/j.bone.2017.09.004_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10456-014-9457-y","article-title":"A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis","volume":"18","author":"Kerr","year":"2015","journal-title":"Angiogenesis"},{"issue":"Pt 5","key":"10.1016\/j.bone.2017.09.004_bb0250","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S2059798316003624","article-title":"Crystal structures of apo and inhibitor-bound TGFbetaR2 kinase domain: insights into TGFbetaR isoform selectivity","volume":"72","author":"Tebben","year":"2016","journal-title":"Acta Crystallogr. D Struct. Biol."},{"issue":"9","key":"10.1016\/j.bone.2017.09.004_bb0255","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bmcl.2017.03.026","article-title":"Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors","volume":"27","author":"Sabat","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bone.2017.09.004_bb0260","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12012-014-9297-4","article-title":"Cardiac safety of TGF-beta receptor I kinase inhibitor LY2157299 monohydrate in cancer patients in a first-in-human dose study","volume":"15","author":"Kovacs","year":"2015","journal-title":"Cardiovasc. Toxicol."},{"issue":"6","key":"10.1016\/j.bone.2017.09.004_bb0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3460","article-title":"Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches","volume":"14","author":"Fairclough","year":"2013","journal-title":"Nat. Rev. Genet."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821730340X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821730340X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T11:34:10Z","timestamp":1532518450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821730340X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":53,"alternative-id":["S875632821730340X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.09.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}